Metoprolol Succinate ER Side Effects

Generic name: metoprolol

Medically reviewed by Drugs.com. Last updated on Sep 20, 2023.

Note: This document provides detailed information about Metoprolol Succinate ER.

For healthcare professionals

Applies to metoprolol: compounding powder, injectable solution, oral capsule extended release, oral solution, oral tablet, oral tablet extended release Side Effects associated with metoprolol. Some dosage forms listed on this page may not apply specifically to the brand name Metoprolol Succinate ER.

For healthcare professionals

Applies to metoprolol: compounding powder, injectable solution, oral capsule extended release, oral solution, oral tablet, oral tablet extended release.

General

The most common adverse reactions were tiredness, dizziness, depression, shortness of breath, bradycardia, hypotension, diarrhea, pruritus, and rash.^[Ref]

Cardiovascular

• Very common (10% or more): Heart failure (up to 27.5%), hypotension (systolic blood pressure less than 90 mmHg) (up to 27.4%), bradycardia (heart rate less than 40 beats per minute) (up to 15.9%),
• Common (1% to 10%): Cold extremities, arterial insufficiency, palpitation, first degree heart block (P-R interval 0.26 seconds or greater), second or third degree heart block, postural disorders
• Uncommon (0.1% to 1%): Cardiogenic shock in patients with acute myocardial infarction
• Rare (0.01% to 0.1%): Disturbances of cardiac conduction, cardiac arrhythmia
• Very rare (less than 0.01%): Intermittent claudication increased
• Frequency not reported: Claudication^[Ref]

Gastrointestinal

• Common (1% to 10%): Diarrhea, nausea, dry mouth, gastric pain, constipation, flatulence, heartburn, abdominal pain, vomiting
• Frequency not reported: Retroperitoneal fibrosis^[Ref]

Other

• Common (1% to 10%): Tiredness, peripheral edema, accident and/or injury, death, fatigue
• Uncommon (0.1% to 1%): Edema, precordial pain
• Frequency not reported: Lactic dehydrogenase elevated
• Postmarketing reports: Chest pain^[Ref]

Nervous system

• Common (1% to 10%): Dizziness, vertigo, stroke, headache
• Uncommon (0.1% to 1%): Paresthesia, somnolence, impaired concentration
• Rare (0.01% to 0.1%): Alertness decreased
• Very rare (less than 0.01%): Amnesia/memory impairment, tinnitus, taste disturbance
• Frequency not reported: Short-term memory loss
• Postmarketing reports: Syncope^[Ref]

Respiratory

• Common (1% to 10%): Shortness of breath, wheezing, dyspnea
• Rare (less than 0.1%): Rhinitis^[Ref]

Dermatologic

• Common (1% to 10%): Pruritus, rash
• Uncommon (0.1% to 1%): Sweating increased
• Rare (0.01% to 0.1%): Loss of hair
• Very rare (less than 0.01%): Photosensitivity reactions, psoriasis aggravated, gangrene in patients with preexisting severe peripheral circulatory disorders, hyperhidrosis, alopecia^[Ref]

Psychiatric

• Common (1% to 10%): Depression
• Uncommon (0.1% to 1%): Insomnia, nightmare
• Rare (0.01% to 0.1%): Nervousness, anxiety
• Very rare (less than 0.01%): Confusion, hallucination, personality disorder, disturbances of libido
• Frequency not reported: Sleep disturbance^[Ref]

Musculoskeletal

• Uncommon (0.1% to 1%): Muscle cramps
• Very rare (less than 0.01%): Arthralgia, arthritis
• Frequency not reported: Musculoskeletal pain^[Ref]

Metabolic

• Uncommon (0.1% to 1%): Weight gain
• Frequency not reported: Unstable diabetes
• Postmarketing reports: Blood triglycerides increased, high density lipoprotein (HDL) decreased^[Ref]

Ocular

• Rare (less than 0.1%): Visual disturbance, dry and/or irritated eyes, conjunctivitis
• Frequency not reported: Blurred vision^[Ref]

Hepatic

• Rare (0.01% to 0.1%): Liver function test abnormalities
• Very rare (less than 0.01%): Hepatitis
• Frequency not reported: Transaminase elevated, alkaline phosphatase elevated
• Postmarketing reports: Jaundice, non-specific hepatic dysfunction^[Ref]

Genitourinary

• Rare (0.01% to 0.1%): Impotence/sexual dysfunction
• Very rare (less than 0.01%): Peyronie's disease^[Ref]

Immunologic

• Rare (less than 0.1%): Positive antinuclear antibodies^[Ref]

Hematologic

• Very rare (less than 0.01%): Thrombocytopenia
• Frequency not reported: Agranulocytosis^[Ref]

Frequently asked questions

• Metoprolol Succinate vs Tartrate: What's the difference between them?
• Which is safer: metoprolol succinate or tartrate?
• What is the best time of day to take blood pressure medication?
• Does metoprolol make you sleepy?
• Does metoprolol cause hair loss?
• How long does Metoprolol stay in your system after you stop taking it?
• How long does it take for metoprolol to work?

Further information

Metoprolol Succinate ER side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.

Medical Disclaimer